Search Results 1201-1210 of 17627 for treatment resistant depression
... treating patients with B-cell non-Hodgkin lymphoma that has returned (recurrent) or did not respond to treatment (refractory). Monoclonal antibodies, such ...
By condition, treatment or drug name. Search tips ... Resistant to Hydroxyurea. Print details. Share ... treatment has been approved and is on the market.
The purpose of this study is to evaluate HPN217 as monotherapy to assess the safety, tolerability and pharmacokinetics in patients with relapsed/ refractory ...
By condition, treatment or drug name ... treatment tools to treat those with a mental health illness. ... depression, disruptive behavior); English speaking ...
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic ...
Rochester, Minn. The purpose of this study is to determine the safety and best dose of PRGN-3006 T Cells to treat relapsed/refractory Acute Myeloid Leukemia and ...
Treatment Approach of Refractory ... Telephone-based, cognitive-behavioral therapy for African American dementia caregivers with depression: initial findings.
By condition, treatment or drug name. Search tips ... Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant ...
Transcranial magnetic stimulation, Teen depression, Mood disorder, Childhood-onset disorder. Request an appointment · Conditions treatedSpecialty groups. July ...
Participant has any other medical condition, such as anxiety, depression, heart disease, or significant hepatic, pulmonary, or renal disease, that requires them ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!